Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin resistance7794 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A26168 | 20966900 | Obesity (Silver Spring) | Cognitive-behavioral treatment of nonalcoholic Fatty liver disease: a propensity score-adjusted observational study. | 2010 | Details |
A26169 | 20965162 | Eur J Pharmacol | The ameliorating effect of rosiglitazone on experimental nonalcoholic steatohepatitis is associated with regulating adiponectin receptor expression in rats. | 2010 | Details |
A26171 | 20961734 | Nutrition | Nutrient intake in Italian obese patients: relationships with insulin resistance and markers of non-alcoholic fatty liver disease. | 2010 | Details |
A26172 | 20961180 | Scand J Clin Lab Invest | Variations in alanine aminotransferase levels within the normal range predict metabolic and androgenic phenotypes in women of reproductive age. | 2010 | Details |
A26173 | 20960378 | Semin Liver Dis | Novel insights into the pathophysiology of nonalcoholic fatty liver disease. | 2010 | Details |
A26175 | 20955971 | Best Pract Res Clin Gastroenterol | Nonalcoholic fatty liver disease. | 2010 | Details |
A26177 | 20953581 | Diabetologia | Dissociation between fatty liver and insulin resistance: the role of adipose triacylglycerol lipase. | 2010 | Details |
A26180 | 20946638 | Lipids Health Dis | Exercise counteracts fatty liver disease in rats fed on fructose-rich diet. | 2010 | Details |
A26181 | 20945272 | Horm Metab Res | A promoter polymorphism in the liver-specific fatty acid transport protein 5 is associated with features of the metabolic syndrome and steatosis. | 2010 | Details |
A26184 | 20942739 | Scand J Clin Lab Invest | Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease. | 2010 | Details |
A26186 | 20939106 | World J Gastroenterol | Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis. | 2010 | Details |
A26187 | 20939105 | World J Gastroenterol | Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. | 2010 | Details |
A26197 | 20926473 | Ann Clin Biochem | Serum fetuin A/α2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis. | 2010 | Details |
A26199 | 20923528 | J Diabetes | Genistein improves liver function and attenuates non-alcoholic fatty liver disease in a rat model of insulin resistance. | 2009 | Details |
A26200 | 20922498 | Obes Surg | NAFLD and insulin resistance do not increase the risk of postoperative complications among patients undergoing bariatric surgery--a prospective analysis. | 2011 | Details |
A26202 | 20890895 | Hepatology | Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter. | 2010 | Details |
A26203 | 20890890 | Hepatology | Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease. | 2010 | Details |
A26204 | 20888782 | Trends Endocrinol Metab | JNK regulation of hepatic manifestations of the metabolic syndrome. | 2010 | Details |
A26205 | 20888662 | J Hepatol | Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C. | 2010 | Details |
A26209 | 20887595 | Hepatol Res | Lower circulating levels of dehydroepiandrosterone, independent of insulin resistance, is an important determinant of severity of non-alcoholic steatohepatitis in Japanese patients. | 2010 | Details |
A26212 | 20880682 | Nutr Metab Cardiovasc Dis | Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children. | 2010 | Details |
A26213 | 20880342 | Diabetes Obes Metab | Potential therapeutic uses for ezetimibe beyond lowering LDL-c to decrease cardiovascular events. | 2010 | Details |
A26217 | 28839568 | Frontline Gastroenterol | Practical management of the increasing burden of non-alcoholic fatty liver disease. | 2010 | Details |
A26222 | 20872965 | World J Gastroenterol | Roles of liver innate immune cells in nonalcoholic fatty liver disease. | 2010 | Details |
A26223 | 20871475 | Pancreas | Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease. | 2010 | Details |
A26224 | 20869214 | Exp Toxicol Pathol | Swimming training beneficial effects in a mice model of nonalcoholic fatty liver disease. | 2010 | Details |
A26225 | 20869086 | Metabolism | Plasma levels of asymmetric dimethylarginine in patients with biopsy-proven nonalcoholic fatty liver disease. | 2010 | Details |
A26227 | 20865675 | Cardiol J | Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease. | 2010 | Details |
A26228 | 20865648 | Horm Metab Res | Metabolic parameters and nonalcoholic fatty liver disease in hypopituitary men. | 2010 | Details |
A26233 | 20851820 | QJM | Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling--a propensity score-adjusted observational study. | 2010 | Details |
A26239 | 20847373 | Indian J Med Res | Association of hypoadiponectinemia with non-alcoholic fatty liver disease in urban south Indians--(CURES - 81). | 2010 | Details |
A26243 | 20845385 | Biotechnol J | Hepatoprotective effect of oleuropein in mice: mechanisms uncovered by gene expression profiling. | 2010 | Details |
A26247 | 20842181 | Nat Rev Endocrinol | Morbid obesity in pediatric diabetes mellitus: surgical options and outcomes. | 2010 | Details |
A26249 | 20842026 | Curr Opin Clin Nutr Metab Care | Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data. | 2010 | Details |
A26250 | 20840346 | J Eur Acad Dermatol Venereol | Psoriasis and non-alcoholic fatty liver disease. | 2010 | Details |
A26251 | 20838401 | Int J Obes (Lond) | Nonalcoholic fatty liver disease: a challenge for pediatricians. | 2010 | Details |
A26257 | 20825652 | BMC Gastroenterol | Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study. | 2010 | Details |
A26259 | 20818807 | World J Gastroenterol | Obstructive sleep apnea syndrome and fatty liver: association or causal link? | 2010 | Details |
A26260 | 20818484 | Int J Mol Med | Oxidative stress parameters in paediatric non-alcoholic fatty liver disease. | 2010 | Details |
A26263 | 20817213 | Metabolism | Nonalcoholic steatohepatitis and increased risk of chronic kidney disease. | 2010 | Details |
A26266 | 20809771 | Scand J Gastroenterol | Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease. | 2010 | Details |
A26270 | 20805868 | PLoS One | Serum dipeptidyl peptidase-4 activity in insulin resistant patients with non-alcoholic fatty liver disease: a novel liver disease biomarker. | 2010 | Details |
A26272 | 20804522 | Obes Rev | Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? | 2010 | Details |
A26273 | 20803499 | Hepatology | A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. | 2010 | Details |
A26276 | 20801629 | J Nutr Biochem | Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice. | 2010 | Details |
A26278 | 20798875 | J Obes | Comparative evaluation of whole body and hepatic insulin resistance using indices from oral glucose tolerance test in morbidly obese subjects with nonalcoholic Fatty liver disease. | 2010 | Details |
A26288 | 20721461 | Arq Gastroenterol | Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals. | 2010 | Details |
A26289 | 20720269 | Ann Hepatol | Prevalence of type 2 diabetes mellitus and chronic liver disease: a retrospective study of the association of two increasingly common diseases in Mexico. | 2010 | Details |
A26294 | 20701585 | Curr Diabetes Rev | Interrelationships between hepatic fat and insulin resistance in non-alcoholic fatty liver disease. | 2010 | Details |
A26296 | 20694293 | Nutr Hosp | Role of -55CT polymorphism of UCP3 gene on non alcoholic fatty liver disease and insulin resistance in patients with obesity. | 2011 | Details |
A26297 | 20687985 | Acta Med Port | [Association of gamma glutamyltransferase, metabolic syndrome and cardiovascular risk]. | 2010 | Details |
A26310 | 20664312 | Korean J Gastroenterol | [Nonalcoholic fatty liver disease]. | 2010 | Details |
A26312 | 20661251 | Int J Obes (Lond) | Visceral adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic NAFLD-related portal hypertension. | 2010 | Details |
A26314 | 20660697 | Gut | Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. | 2010 | Details |
A26316 | 20658156 | J Gastroenterol | Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease. | 2010 | Details |
A26321 | 20653983 | Lipids Health Dis | Preventive effects of chronic exogenous growth hormone levels on diet-induced hepatic steatosis in rats. | 2010 | Details |
A26322 | 20651844 | Biochem Cell Biol | Calorie restriction on insulin resistance and expression of SIRT1 and SIRT4 in rats. | 2010 | Details |
A26323 | 20651599 | Eur J Gastroenterol Hepatol | Treatment with omega-3 fatty acids but not exendin-4 improves hepatic steatosis. | 2010 | Details |
A26325 | 20648476 | Hepatology | Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. | 2010 | Details |
A26326 | 20648474 | Hepatology | I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. | 2010 | Details |
A26329 | 20645852 | Annu Rev Nutr | The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. | 2010 | Details |
A26337 | 20628364 | Am J Gastroenterol | Impact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c levels in nondiabetic subjects. | 2010 | Details |
A26338 | 20627036 | Zhonghua Nei Ke Za Zhi | [Serum omega-3 polyunsaturated fatty acid and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease]. | 2010 | Details |
A26342 | 20625647 | Arq Bras Endocrinol Metabol | Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2010 | Details |
A26344 | 20624207 | Liver Int | The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitis. | 2010 | Details |
A26353 | 20604719 | Scand J Clin Lab Invest | Circulating levels of interleukin-18 in patients with non-alcoholic fatty liver disease. | 2010 | Details |
A26356 | 20601094 | Drug Discov Today | Ezetimibe as a potential treatment for non-alcoholic fatty liver disease: is the intestine a modulator of hepatic insulin sensitivity and hepatic fat accumulation? | 2010 | Details |
A26361 | 20590731 | Diabetes Obes Metab | Acupuncture: is it effective for treatment of insulin resistance? | 2010 | Details |
A26362 | 20587319 | Zhonghua Gan Zang Bing Za Zhi | [The relationship of leptin and adiponectin with insulin resistance in nonalcoholic fatty liver disease]. | 2010 | Details |
A26364 | 20584230 | Int J Clin Pract | Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease. | 2010 | Details |
A26367 | 20580331 | Dig Liver Dis | Relationship between portal chronic inflammation and disease severity in paediatric non-alcoholic fatty liver disease. | 2010 | Details |
A26368 | 20580037 | Metabolism | Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease. | 2010 | Details |
A26369 | 20579864 | J Nutr Biochem | Serum adipocyte-specific fatty acid-binding protein is associated with nonalcoholic fatty liver disease in apparently healthy subjects. | 2010 | Details |
A26372 | 20576005 | Obes Rev | Melanin and melanogenesis in adipose tissue: possible mechanisms for abating oxidative stress and inflammation? | 2011 | Details |
A26376 | 20569523 | Proc Nutr Soc | The importance of fatty liver disease in clinical practice. | 2010 | Details |
A26377 | 20567026 | J Lipid Res | Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats. | 2010 | Details |
A26379 | 20561029 | Eur J Clin Invest | Assessment of liver stiffness in subjects affected by familial combined hyperlipidaemia with hepatic steatosis. | 2010 | Details |
A26380 | 20560816 | Scand J Gastroenterol | A novel non-alcoholic steatohepatitis animal model featured with insulin resistance, hepatic inflammation and fibrosis. | 2010 | Details |
A26383 | 20556538 | Obes Surg | Nonalcoholic fatty liver disease associated with obstructive sleep apnea: just a coincidence? | 2010 | Details |
A26385 | 20554486 | Dig Liver Dis | Adiponectin isoforms, insulin resistance and liver histology in nonalcoholic fatty liver disease. | 2010 | Details |
A26386 | 20553760 | Prog Lipid Res | Biosynthesis and bioavailability of long-chain polyunsaturated fatty acids in non-alcoholic fatty liver disease. | 2010 | Details |
A26389 | 20546964 | J Hepatol | The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life. | 2010 | Details |
A26390 | 20537997 | Gastroenterology | Genetic covariance between gamma-glutamyl transpeptidase and fatty liver risk factors: role of beta2-adrenergic receptor genetic variation in twins. | 2010 | Details |
A26393 | 20531177 | Curr Opin Clin Nutr Metab Care | Nonalcoholic fatty liver disease in children. | 2010 | Details |
A26395 | 20529259 | BMC Gastroenterol | Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study. | 2010 | Details |
A26400 | 20518077 | World J Gastroenterol | Soft drinks consumption and nonalcoholic fatty liver disease. | 2010 | Details |
A26401 | 20513351 | Biochem Biophys Res Commun | Chromium attenuates high-fat diet-induced nonalcoholic fatty liver disease in KK/HlJ mice. | 2010 | Details |
A26404 | 23148155 | Ther Adv Endocrinol Metab | Advances in the treatment of nonalcoholic fatty liver disease. | 2010 | Details |
A26405 | 22444262 | Animal | Porcine models for the metabolic syndrome, digestive and bone disorders: a general overview. | 2010 | Details |
A26406 | 20507559 | Nutr J | Assessment of insulin resistance by a 13C glucose breath test: a new tool for early diagnosis and follow-up of high-risk patients. | 2010 | Details |
A26413 | 20498498 | Postepy Hig Med Dosw (Online) | [The role of adipokines and insulin resistance in the pathogenesis of nonalcoholic fatty liver disease]. | 2010 | Details |
A26418 | 20492324 | J Gastroenterol Hepatol | A fresh look at NASH pathogenesis. Part 1: the metabolic movers. | 2010 | Details |
A26420 | 20490316 | J Clin Biochem Nutr | A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet. | 2010 | Details |
A26422 | 20485253 | Minerva Gastroenterol Dietol | Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease. | 2010 | Details |
A26425 | 20477484 | Biomark Med | Can nonalcoholic steatohepatitis be diagnosed without liver biopsy? | 2009 | Details |
A26428 | 20473151 | Curr Opin Clin Nutr Metab Care | Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammation. | 2010 | Details |
A26429 | 20472517 | Dig Liver Dis | Relationship between white blood cell count and nonalcoholic fatty liver disease. | 2010 | Details |
A26437 | 20460921 | Dig Dis | Endocannabinoids and their role in fatty liver disease. | 2010 | Details |
A26439 | 20460919 | Dig Dis | Animal models of non-alcoholic steatohepatitis: of mice and man. | 2010 | Details |
A26441 | 20460917 | Dig Dis | Molecular mechanisms of hepatic fibrosis in non-alcoholic steatohepatitis. | 2010 | Details |